Semi-Supervised Skin Lesion Segmentation under Dual Mask Ensemble with Feature Discrepancy Co-Training

Published: 27 Mar 2025, Last Modified: 01 May 2025MIDL 2025 PosterEveryoneRevisionsBibTeXCC BY 4.0
Keywords: Semi-Supervised Learning, Skin cancer diagnosis, Co-training Network
TL;DR: A novel feature discrepancy loss trained with a cross-pseudo supervision strategy and Dual Mask Ensemble training that enables the sub-models to extract more meaningful information from unlabeled data by combining mask predictions.
Abstract: Skin Lesion Segmentation with supportive Deep Learning has become essential in skin lesion analysis and skin cancer diagnosis. However, in the practical scenario of clinical implementation, there is a limitation in human-annotated labels for training data, which leads to poor performance in supervised training models. In this paper, we propose Dual Mask Ensemble (DME) based on a dual-branch co-training network, which aims to enforce two models to exploit information from different views. Specifically, we introduce a novel feature discrepancy loss trained with a cross-pseudo supervision strategy, which enhances model representation by encouraging the sub-networks to learn from distinct features, thereby mitigating feature collapse. Additionally, Dual Mask Ensemble training enables the sub-models to extract more meaningful information from unlabeled data by combining mask predictions. Experimental results demonstrate the effectiveness of our approach, achieving state-of-the-art performance across several metrics (Dice and Jaccard) on the ISIC2018 and HAM10000 datasets. Our code is available at https://github.com/antares0811/DME-FD.
Primary Subject Area: Learning with Noisy Labels and Limited Data
Secondary Subject Area: Application: Dermatology
Paper Type: Methodological Development
Registration Requirement: Yes
Reproducibility: https://github.com/antares0811/DME-FD
Visa & Travel: Yes
Submission Number: 94
Loading

OpenReview is a long-term project to advance science through improved peer review with legal nonprofit status. We gratefully acknowledge the support of the OpenReview Sponsors. © 2025 OpenReview